Back to feed

NCT02137252

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Naltrexone Randomized Controlled Trial for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

ClinicalTrials.gov
Sponsor
Dana-Farber Cancer Institute
Status
Terminated
Versions
8
Adjacent patches
7
Severity is deterministic, reproducible, uncalibrated triage metadata, not validated review priority or proven wrongdoing. New Evidence Record packages are generated for deterministic event-class membership, not by triage rank alone.

Material event timeline

4 shown
Triage: Low
2016-07-29
Administrative Contact Change
v3 to v4 Early Recruitment Inspect patch
/protocolSection/contactsLocationsModule/centralContacts
/protocolSection/contactsLocationsModule/locations/0/contacts
/protocolSection/contactsLocationsModule/locations/0/status
Triage: Medium
2018-02-08
Timeline Significant Shift
v4 to v5 Late Recruitment Inspect patch
/protocolSection/statusModule/lastUpdatePostDateStruct/date
/protocolSection/statusModule/lastUpdatePostDateStruct/type
/protocolSection/statusModule/lastUpdateSubmitDate
Triage: High
2019-05-31
Enrollment Change
v5 to v6 Late Recruitment Inspect patch
/annotationSection
/protocolSection/designModule/enrollmentInfo/count
/protocolSection/designModule/enrollmentInfo/type
Triage: High
2021-11-12
Arm Intervention Change
v6 to v7 Post Recruitment Inspect patch Evidence Record
/annotationSection
/documentSection
/hasResults